Matthew Taylor

Assistant Professor

    • 1475 Citations
    • 7 h-Index
    20102017

    Research Output 2010 2017

    • 1475 Citations
    • 7 h-Index
    • 11 Article
    • 1 Comment/debate
    Filter
    Article
    2017
    1 Citations

    Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, in patients with advanced solid tumors

    Burris, H. A., Infante, J. R., Ansell, S. M., Nemunaitis, J. J., Weiss, G. R., Villalobos, V. M., Sikic, B. I., Taylor, M. H., Northfelt, D. W., Carson, W. E., Hawthorne, T. R., Davis, T. A., Yellin, M. J., Keler, T. & Bullock, T. Jun 20 2017 In : Journal of Clinical Oncology. 35, 18, p. 2028-2036 9 p.

    Research output: Research - peer-reviewArticle

    Anti-Idiotypic Antibodies
    Safety
    Neoplasms
    T-Lymphocytes
    Disease-Free Survival
    2016
    3 Citations

    Characterization of tumor size changes over time from the phase 3 study of lenvatinib in thyroid cancer

    Robinson, B., Schlumberger, M., Wirth, L. J., Dutcus, C. E., Song, J., Taylor, M. H., Kim, S. B., Krzyzanowska, M. K., Capdevila, J., Sherman, S. I. & Tahara, M. Nov 1 2016 In : Journal of Clinical Endocrinology and Metabolism. 101, 11, p. 4103-4109 7 p.

    Research output: Research - peer-reviewArticle

    Thyroid Neoplasms
    Neoplasms
    lenvatinib
    Tumors
    Disease-Free Survival
    96 Citations

    Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial

    Hodi, F. S. , Chesney, J. , Pavlick, A. C. , Robert, C. , Grossmann, K. F. , McDermott, D. F. , Linette, G. P. , Meyer, N. , Giguere, J. K. , Agarwala, S. S. , Shaheen, M. , Ernstoff, M. S. , Minor, D. R. , Salama, A. K. , Taylor, M. H. , Ott, P. A. , Horak, C. , Gagnier, P. , Jiang, J. , Wolchok, J. D. & 1 others Postow, M. A. Nov 1 2016 In : The Lancet Oncology. 17, 11, p. 1558-1568 11 p.

    Research output: Research - peer-reviewArticle

    Melanoma
    Survival
    nivolumab
    ipilimumab
    Therapeutics
    125 Citations

    Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): A multicentre, open-label, phase 1/2 trial

    Antonia, S. J. , López-Martin, J. A. , Bendell, J. , Ott, P. A. , Taylor, M. , Eder, J. P. , Jäger, D. , Pietanza, M. C. , Le, D. T. , de Braud, F. , Morse, M. A. , Ascierto, P. A. , Horn, L. , Amin, A. , Pillai, R. N. , Evans, J. , Chau, I. , Bono, P. , Atmaca, A. , Sharma, P. & 4 others Harbison, C. T., Lin, C. S., Christensen, O. & Calvo, E. 2016 (Accepted/In press) In : The Lancet Oncology.

    Research output: Research - peer-reviewArticle

    Small Cell Lung Carcinoma
    nivolumab
    ipilimumab
    Therapeutics
    Safety
    1 Citations

    Open-label, multicenter, phase 1 study of alisertib (MLN8237), an aurora A kinase inhibitor, with docetaxel in patients with solid tumors

    Graff, J. N., Higano, C. S., Hahn, N. M., Taylor, M. H., Zhang, B., Zhou, X., Venkatakrishnan, K., Leonard, E. J. & Sarantopoulos, J. Aug 15 2016 In : Cancer. 122, 16, p. 2524-2533 10 p.

    Research output: Research - peer-reviewArticle

    docetaxel
    Aurora Kinase A
    Neoplasms
    MLN 8237
    Pharmacokinetics
    1 Citations

    Treatment patterns, health state, and health care resource utilization of patients with radioactive iodine refractory differentiated thyroid cancer

    Gianoukakis, A. G., Flores, N. M., Pelletier, C. L., Forsythe, A., Wolfe, G. R. & Taylor, M. H. May 30 2016 In : Cancer Management and Research. 8, p. 67-76 10 p.

    Research output: Research - peer-reviewArticle

    Patient Acceptance of Health Care
    Health Resources
    Thyroid Neoplasms
    Iodine
    Health
    2015
    10 Citations

    Fibroblast Growth Factor Signaling Controls Liver Size in Mice with Humanized Livers

    Naugler, W. E., Tarlow, B. D., Fedorov, L. M., Taylor, M., Pelz, C., Li, B., Darnell, J. & Grompe, M. Sep 1 2015 In : Gastroenterology. 149, 3, p. 728e15-740e15

    Research output: Research - peer-reviewArticle

    Fibroblast Growth Factors
    Liver
    Bile Acids and Salts
    Hepatocytes
    Body Weight
    253 Citations

    Lenvatinib versus placebo in radioiodine-refractory thyroid cancer

    Schlumberger, M., Tahara, M., Wirth, L. J., Robinson, B., Brose, M. S., Elisei, R., Habra, M. A., Newbold, K., Shah, M. H., Hoff, A. O., Gianoukakis, A. G., Kiyota, N., Taylor, M. H., Kim, S. B., Krzyzanowska, M. K., Dutcus, C. E., De Las Heras, B., Zhu, J. & Sherman, S. I. Feb 12 2015 In : New England Journal of Medicine. 372, 7, p. 621-630 10 p.

    Research output: Research - peer-reviewArticle

    Thyroid Neoplasms
    Placebos
    lenvatinib
    Iodine
    Disease-Free Survival
    785 Citations

    Nivolumab and ipilimumab versus ipilimumab in untreated melanoma

    Postow, M. A. , Chesney, J. , Pavlick, A. C. , Robert, C. , Grossmann, K. , McDermott, D. , Linette, G. P. , Meyer, N. , Giguere, J. K. , Agarwala, S. S. , Shaheen, M. , Ernstoff, M. S. , Minor, D. , Salama, A. K. , Taylor, M. , Ott, P. A. , Rollin, L. M. , Horak, C. , Gagnier, P. , Wolchok, J. D. & 1 others Hodi, F. S. May 21 2015 In : New England Journal of Medicine. 372, 21, p. 2006-2017 12 p.

    Research output: Research - peer-reviewArticle

    Melanoma
    ipilimumab
    nivolumab
    Placebos
    Neoplasms
    2014
    7 Citations

    Medical Therapy for Advanced Forms of Thyroid Cancer

    Rajhbeharrysingh, U., Taylor, M. & Milas, M. 2014 In : Surgical Clinics of North America. 94, 3, p. 541-571 31 p.

    Research output: Research - peer-reviewArticle

    2010
    193 Citations

    The ploidy conveyor of mature hepatocytes as a source of genetic variation

    Duncan, A. W., Taylor, M. H., Hickey, R. D., Hanlon Newell, A. E., Lenzi, M. L., Olson, S. B., Finegold, M. J. & Grompe, M. Oct 7 2010 In : Nature. 467, 7316, p. 707-710 4 p.

    Research output: Research - peer-reviewArticle

    Ploidies
    Hepatocytes
    Polyploidy
    Chromosomes
    Artificial Cells